cost-effectiveness research

Research in Review

Lung Cancer Screening Is Cost-Effective, Identifies Other Conditions in High-Risk Patients

07/03/2017

JCP Editors

Analysis of high-risk lung cancer screening shows that screening is cost-effective and may offer cost savings if noncurative treatment costs continue to rise, according to new research published in the Journal of...

...

07/03/2017

Journal of Clinical Pathways

Research in Review

Post-Surgery Complications for Gastric Cancer Significantly Raise Hospital Costs

06/29/2017

JCP Editors

Major complications following total gastrectomy for gastric adenocarcinoma can triple the amount of standard hospital costs, according to research published in JAMA Surgery (published online June 28, 2017;...

Major...

06/29/2017

Journal of Clinical Pathways

Research in Review

Best Cost-Effective Option for Breakthrough Cancer Pain Revealed

06/28/2017

JCP Editors

A cost-effectiveness analysis assessed oral fentanyl formulations available for the treatment of breakthrough cancer pain, published in PLOS One (published online June 27, 2017;...

A...

06/28/2017

Journal of Clinical Pathways

Research in Review

Cost-Effective Substitute for Breast Cancer MRI Identified

06/26/2017

JCP Editors

A recent analysis reports a cost-effective alternative modality that demonstrates similar efficacy to traditional breast magnetic resonance imaging (MRI), published in the American Journal of Roentgenology (June...

A...

06/26/2017

Journal of Clinical Pathways

Research in Review

Personalized Dosing More Cost-Effective for NSCLC Treatment

06/15/2017

JCP Editors

A recent budget analysis evaluated the costs, safety, and efficacy of personalized dosing compared with fixed dosing of standard-of-care treatment for non-small cell lung cancer, presented at the 2017 ASCO Annual...

A...

06/15/2017

Journal of Clinical Pathways

Research in Review

Reducing Cancer Drug Waste May Lead to Significant Cost Savings

06/13/2017

JCP Editors

Mitigation strategies may save up to 17% annually in parenteral anticancer drug costs, according to a study published in the Journal of Oncology Practice (published online June 12, 2017;...

...

06/13/2017

Journal of Clinical Pathways

Research in Review

Cost-Effectiveness Analysis Reveals Optimal Screening Strategy for Prostate Cancer

05/23/2017

JCP Editors

A diagnostic magnetic resonance imaging (MRI) scan followed by an MRI-guided biopsy strategy is more cost-effective than an invasive transrectal ultrasound for detecting prostate cancer, according to research...

A...

05/23/2017

Journal of Clinical Pathways

Research Reports

Cost-Effectiveness of a Patient Navigation Program for Colorectal Cancer Screening

05/12/2017

Whitney C Rhodes, PhD, MSPA

Yvonne Kellar-Guenther, PhD

Arnold H Levinson, PhD, MJ

Andrea Dwyer, BS

R Mark Gritz, PhD

Abstract: Patient navigators (PNs) support colorectal screening through increased attendance and improved bowel preparation and are now frequently embedded in primary care settings. In order to determine whether...

...

05/12/2017

Journal of Clinical Pathways

Research in Review

Cost-Effectiveness of Early-Stage Breast Cancer Treatment Options Vary Significantly

04/21/2017

JCP Editors

Certain therapy options for early-stage breast cancer have fewer associated complications and are much less expensive than others, according to a study published in the Journal of the National Cancer Institute...

...

04/21/2017

Journal of Clinical Pathways

Department

Pazopanib More Cost-Effective Than Sunitinib for Patients With Renal Cell Carcinoma

04/12/2017

JCP Editors

Medicare patients with advanced renal cell carcinoma benefit from lower costs and hospital admissions if treated with pazopanib (Votrient, Novartis) rather than sunitinib (Sutent, Pfizer). Advanced renal cell...

...

04/12/2017

Journal of Clinical Pathways